Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 132,572 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $0.49 per share, with a total value of $64,960.28. Following the transaction, the chief executive officer now directly owns 4,029,588 shares of the company’s stock, valued at $1,974,498.12. This represents a 3.40 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Grigorios Siokas also recently made the following trade(s):
- On Monday, February 24th, Grigorios Siokas bought 354,296 shares of Cosmos Health stock. The shares were acquired at an average price of $0.56 per share, with a total value of $198,405.76.
- On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The shares were acquired at an average price of $0.66 per share, with a total value of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas bought 38,900 shares of Cosmos Health stock. The shares were acquired at an average price of $0.77 per share, with a total value of $29,953.00.
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The shares were acquired at an average price of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas bought 62,500 shares of Cosmos Health stock. The shares were acquired at an average price of $0.80 per share, with a total value of $50,000.00.
- On Monday, January 13th, Grigorios Siokas bought 163,666 shares of Cosmos Health stock. The shares were acquired at an average price of $0.61 per share, with a total value of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Price Performance
Shares of Cosmos Health stock opened at $0.48 on Friday. The stock has a 50 day moving average of $0.67 and a 200 day moving average of $0.79. Cosmos Health Inc. has a 12 month low of $0.44 and a 12 month high of $1.58. The firm has a market cap of $11.23 million, a PE ratio of -0.20 and a beta of 5.60. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08.
Hedge Funds Weigh In On Cosmos Health
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Further Reading
- Five stocks we like better than Cosmos Health
- How to Start Investing in Real Estate
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- What is a Low P/E Ratio and What Does it Tell Investors?
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Retail Stocks Investing, Explained
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.